$61.57
-12.61 (-17.00%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-38.68%
1Y
+86.80%
YTD
-30.72%
Open$68.00
Previous Close$74.18
Day High$70.46
Day Low$60.76
52W High$118.84
52W Low$29.95
Volume—
Avg Volume496.3K
Market Cap3.05B
P/E Ratio—
EPS$-10.37
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$97.75
Below
SMA 200
$64.49
Below
RSI (14)
50.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
15 analysts
Price Target
-45.4% upside
Current
$61.57
$61.57
Target
$33.59
$33.59
$28.45
$33.59 avg
$56.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 178.32M | 128.87M | 2.02B |
| Net Income | -494,768,326 | -321,812,165 | 154.03M |
| Profit Margin | -277.5% | -263.6% | 7.6% |
| EBITDA | -518,904,452 | -356,261,638 | 214.07M |
| Free Cash Flow | — | — | 137.52M |
| Rev Growth | +38.4% | +38.4% | +15.5% |
| Debt/Equity | — | — | 0.96 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $245.22 | +0.55% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $407.95 | +0.77% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $133.75 | +2.21% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $782.10 | +1.29% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.68 | +0.72% | 47.7 | 27.52B |